Question to the Cabinet Office:

To ask the Minister for the Cabinet Office, whether the Government (a) is taking steps to ensure the security of genetic data of UK citizens and (b) has raised potential concerns relating to Chinese genomics companies as part of the US-UK Strategic Dialogue on Biological Security.

Organisations which hold sensitive biological data are subject to the UK General Data Protection Regulation (GDPR). In addition, organisations such as Genomics England, UK Biobank and NIHR BioResource consider national security in decision making about partnerships with other companies.

The Office for Life Sciences is undertaking a programme of work to assess how we can minimise the risks from biological data to protect our burgeoning bioeconomy, without stifling innovation, and build confidence in sharing personal data to improve health outcomes in the UK and across the world. This is being conducted in consultation with relevant Departments and Agencies across Government, and key partners such as Genomics England and UK Biobank.

Underpinned by the UK Biological Security Strategy and the U.S. Biodefense Strategy, the U.S.-UK Strategic Dialogue on Biological Security reflects a shared ambition to protect against a growing and diverse spectrum of biological threats. These risks include future pandemics as well as those that might arise from misuse of biotechnology and genomic data by state actors.